Shopping Cart 0
Cart Subtotal
AED 0

GE Healthcare LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cellular technologies; imaging agents used during medical scanning procedures; and a range of healthcare IT solutions. GE Healthcare also provides services such as performance improvement and performance solutions services, computerized data management and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE Healthcare is headquartered in Chicago, Illinois, the US.

GE Healthcare LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deal Details 16

Asset Purchase 16

GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 16

GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For USD 1.06 Billion 17

Venture Financing 18

InSightec Raises Additional USD60 Million in Series E Financing 18

InSightec Raises USD90 Million in Series E Financing 20

Monica Healthcare Raises USD3 Million in Venture Financing 22

Partnerships 24

Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 24

Axiogenesis Enters into Licensing Agreement with GE Healthcare 25

Guangzhou RiboBio Partners with GE Healthcare Life Sciences 26

Golden Meditech Enters into Partnership Agreement with GE Healthcare 27

GE Healthcare and Zai Lab Enter into Agreement 28

Bird Rock Bio Enters into agreement with GE Healthcare 29

Synpromics Enters into Research Agreement with GE Healthcare 30

Boston Children's Hospital Enters into Agreement with GE Healthcare 31

GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 32

Cell Therapy Catapult Enters into Agreement with Asymptote 33

GE Healthcare Enters into R&D Agreement with Takeda Pharma 34

Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 35

GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 36

GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 37

GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 38

GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 39

GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 40

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 41

GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 42

Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 43

Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 44

Licensing Agreements 45

GE Healthcare Enters into Licensing Agreement with StemCell Technologies 45

GE Healthcare Enters into Licensing Agreement with Promosome 46

Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 47

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 48

Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 49

GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 50

GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 51

GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 52

Equity Offering 53

General Electric to Spin Off Healthcare Business 53

Asset Transactions 54

PnuVax to Acquire Inactivated Yellow Fever Vaccine Intellectual Property from GE Healthcare Life Sciences 54

Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 55

Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 56

Acquisition 57

GE Healthcare Acquires Puridify 57

GE Healthcare Acquires Novia Strategies 58

Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 59

GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 60

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 62

GE Healthcare LLC-Key Competitors 63

GE Healthcare LLC-Key Employees 64

GE Healthcare LLC-Locations And Subsidiaries 66

Head Office 66

Other Locations & Subsidiaries 66

Joint Venture 70

Recent Developments 71

Strategy And Business Planning 71

Aug 21, 2018: Swedish Government and GE Healthcare open an innovation center for life sciences 71

Jun 04, 2018: Florida Hospital and GE Healthcare Partners to Build 'Command Center' to Guide Clinical Operations 73

Apr 17, 2018: GE's new factory-in-a-box accelerates the production of viral vector based therapeutics 74

Dec 18, 2017: Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by USD 182 Million over Six Years 75

Corporate Communications 76

Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 76

Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 77

Government and Public Interest 78

Jul 04, 2018: GE, Lagos State Government sign agreement on power, healthcare, skills development 78

Jun 18, 2018: Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing 79

May 30, 2018: New Cell Therapy Could Help Millions Suffering from Back Pain 80

Dec 05, 2017: One reason clinical trials for Alzheimer's disease have failed-And the digital biomarker that could help address that 81

Product News 82

Sep 05, 2017: GE Healthcare advances the delivery of cell therapies with new thawing technology 82

Jun 04, 2018: Feinstein Institute, GE Can Read What Nerves Are Saying About Inflammation 83

Jan 29, 2018: Making Ultrasound More Accessible: GE Healthcare's New Versana Essential Combines Quality and Affordability 84

Other Significant Developments 85

Sep 12, 2018: GE Healthcare to expand OHSU mission control capabilities to support sepsis patient care 85

Jun 07, 2018: GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs 86

May 29, 2018: Tampa General Hospital and GE Healthcare Partner for Next Level Care Coordination 87

Jan 18, 2018: CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare's New Start-to-Finish Solution 88

May 02, 2017: Sygnature Discovery enhances Biophysics capability with addition of Biacore 8K SPR system 89

Feb 20, 2017: Phreesia Selected as a Member of GE Healthcare's Centricity Partner Program 90

Appendix 91

Methodology 91

About GlobalData 91

Contact Us 91

Disclaimer 91


List Of Figure

List of Figures

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

GE Healthcare LLC, Pharmaceuticals & Healthcare, Key Facts, 2017 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 16

GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For USD 1.06 Billion 17

InSightec Raises Additional USD60 Million in Series E Financing 18

InSightec Raises USD90 Million in Series E Financing 20

Monica Healthcare Raises USD3 Million in Venture Financing 22

Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 24

Axiogenesis Enters into Licensing Agreement with GE Healthcare 25

Guangzhou RiboBio Partners with GE Healthcare Life Sciences 26

Golden Meditech Enters into Partnership Agreement with GE Healthcare 27

GE Healthcare and Zai Lab Enter into Agreement 28

Bird Rock Bio Enters into agreement with GE Healthcare 29

Synpromics Enters into Research Agreement with GE Healthcare 30

Boston Children's Hospital Enters into Agreement with GE Healthcare 31

GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 32

Cell Therapy Catapult Enters into Agreement with Asymptote 33

GE Healthcare Enters into R&D Agreement with Takeda Pharma 34

Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 35

GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 36

GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 37

GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 38

GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 39

GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 40

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 41

GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 42

Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 43

Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 44

GE Healthcare Enters into Licensing Agreement with StemCell Technologies 45

GE Healthcare Enters into Licensing Agreement with Promosome 46

Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 47

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 48

Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 49

GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 50

GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 51

GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 52

General Electric to Spin Off Healthcare Business 53

PnuVax to Acquire Inactivated Yellow Fever Vaccine Intellectual Property from GE Healthcare Life Sciences 54

Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 55

Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 56

GE Healthcare Acquires Puridify 57

GE Healthcare Acquires Novia Strategies 58

Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 59

GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 60

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 62

GE Healthcare LLC, Key Competitors 63

GE Healthcare LLC, Key Employees 64

GE Healthcare LLC, Other Locations 66

GE Healthcare LLC, Subsidiaries 67

GE Healthcare LLC, Joint Venture 70

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

GE Healthcare LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cellular technologies; imaging agents used during medical scanning procedures; and a range of healthcare IT solutions. GE Healthcare also provides services such as performance improvement and performance solutions services, computerized data management and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE Healthcare is headquartered in Chicago, Illinois, the US.

GE Healthcare LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 6

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deal Details 16

Asset Purchase 16

GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 16

GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For USD 1.06 Billion 17

Venture Financing 18

InSightec Raises Additional USD60 Million in Series E Financing 18

InSightec Raises USD90 Million in Series E Financing 20

Monica Healthcare Raises USD3 Million in Venture Financing 22

Partnerships 24

Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 24

Axiogenesis Enters into Licensing Agreement with GE Healthcare 25

Guangzhou RiboBio Partners with GE Healthcare Life Sciences 26

Golden Meditech Enters into Partnership Agreement with GE Healthcare 27

GE Healthcare and Zai Lab Enter into Agreement 28

Bird Rock Bio Enters into agreement with GE Healthcare 29

Synpromics Enters into Research Agreement with GE Healthcare 30

Boston Children's Hospital Enters into Agreement with GE Healthcare 31

GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 32

Cell Therapy Catapult Enters into Agreement with Asymptote 33

GE Healthcare Enters into R&D Agreement with Takeda Pharma 34

Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 35

GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 36

GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 37

GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 38

GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 39

GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 40

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 41

GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 42

Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 43

Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 44

Licensing Agreements 45

GE Healthcare Enters into Licensing Agreement with StemCell Technologies 45

GE Healthcare Enters into Licensing Agreement with Promosome 46

Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 47

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 48

Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 49

GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 50

GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 51

GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 52

Equity Offering 53

General Electric to Spin Off Healthcare Business 53

Asset Transactions 54

PnuVax to Acquire Inactivated Yellow Fever Vaccine Intellectual Property from GE Healthcare Life Sciences 54

Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 55

Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 56

Acquisition 57

GE Healthcare Acquires Puridify 57

GE Healthcare Acquires Novia Strategies 58

Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 59

GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 60

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 62

GE Healthcare LLC-Key Competitors 63

GE Healthcare LLC-Key Employees 64

GE Healthcare LLC-Locations And Subsidiaries 66

Head Office 66

Other Locations & Subsidiaries 66

Joint Venture 70

Recent Developments 71

Strategy And Business Planning 71

Aug 21, 2018: Swedish Government and GE Healthcare open an innovation center for life sciences 71

Jun 04, 2018: Florida Hospital and GE Healthcare Partners to Build 'Command Center' to Guide Clinical Operations 73

Apr 17, 2018: GE's new factory-in-a-box accelerates the production of viral vector based therapeutics 74

Dec 18, 2017: Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by USD 182 Million over Six Years 75

Corporate Communications 76

Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 76

Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 77

Government and Public Interest 78

Jul 04, 2018: GE, Lagos State Government sign agreement on power, healthcare, skills development 78

Jun 18, 2018: Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing 79

May 30, 2018: New Cell Therapy Could Help Millions Suffering from Back Pain 80

Dec 05, 2017: One reason clinical trials for Alzheimer's disease have failed-And the digital biomarker that could help address that 81

Product News 82

Sep 05, 2017: GE Healthcare advances the delivery of cell therapies with new thawing technology 82

Jun 04, 2018: Feinstein Institute, GE Can Read What Nerves Are Saying About Inflammation 83

Jan 29, 2018: Making Ultrasound More Accessible: GE Healthcare's New Versana Essential Combines Quality and Affordability 84

Other Significant Developments 85

Sep 12, 2018: GE Healthcare to expand OHSU mission control capabilities to support sepsis patient care 85

Jun 07, 2018: GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs 86

May 29, 2018: Tampa General Hospital and GE Healthcare Partner for Next Level Care Coordination 87

Jan 18, 2018: CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare's New Start-to-Finish Solution 88

May 02, 2017: Sygnature Discovery enhances Biophysics capability with addition of Biacore 8K SPR system 89

Feb 20, 2017: Phreesia Selected as a Member of GE Healthcare's Centricity Partner Program 90

Appendix 91

Methodology 91

About GlobalData 91

Contact Us 91

Disclaimer 91


List Of Figure

List of Figures

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

GE Healthcare LLC, Pharmaceuticals & Healthcare, Key Facts, 2017 2

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

GE Healthcare LLC, Deals By Therapy Area, 2012 to YTD 2018 10

GE Healthcare LLC, Medical Devices Deals, 2012 to YTD 2018 11

GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13

GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 16

GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For USD 1.06 Billion 17

InSightec Raises Additional USD60 Million in Series E Financing 18

InSightec Raises USD90 Million in Series E Financing 20

Monica Healthcare Raises USD3 Million in Venture Financing 22

Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 24

Axiogenesis Enters into Licensing Agreement with GE Healthcare 25

Guangzhou RiboBio Partners with GE Healthcare Life Sciences 26

Golden Meditech Enters into Partnership Agreement with GE Healthcare 27

GE Healthcare and Zai Lab Enter into Agreement 28

Bird Rock Bio Enters into agreement with GE Healthcare 29

Synpromics Enters into Research Agreement with GE Healthcare 30

Boston Children's Hospital Enters into Agreement with GE Healthcare 31

GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 32

Cell Therapy Catapult Enters into Agreement with Asymptote 33

GE Healthcare Enters into R&D Agreement with Takeda Pharma 34

Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 35

GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 36

GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 37

GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 38

GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 39

GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 40

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 41

GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 42

Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 43

Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 44

GE Healthcare Enters into Licensing Agreement with StemCell Technologies 45

GE Healthcare Enters into Licensing Agreement with Promosome 46

Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 47

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 48

Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 49

GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 50

GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 51

GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 52

General Electric to Spin Off Healthcare Business 53

PnuVax to Acquire Inactivated Yellow Fever Vaccine Intellectual Property from GE Healthcare Life Sciences 54

Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 55

Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 56

GE Healthcare Acquires Puridify 57

GE Healthcare Acquires Novia Strategies 58

Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 59

GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 60

IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 62

GE Healthcare LLC, Key Competitors 63

GE Healthcare LLC, Key Employees 64

GE Healthcare LLC, Other Locations 66

GE Healthcare LLC, Subsidiaries 67

GE Healthcare LLC, Joint Venture 70

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

GE Healthcare LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.